设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Springer电子图书(1)
CNKI会议论文(2)
CNKI学位论文(2623)
CNKI期刊论文0611(1)
知网期刊论文(5518)
在“
SpringerLink电子期刊
”中,
命中:
1,065
条,耗时:0.0189891 秒
在所有数据库中总计命中:
8,145
条
1.
Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable
stage
III non-small-cell lung cancer
作者:
Samer Tabchi
;
Normand Blais
;
Marie-Pierre Campeau…
关键词:
Stage
III
NSCLC
;
Locally advanced
NSCLC
;
Chemotherapy
;
Definitive chemoradiotherapy
刊名:Cancer Chemotherapy and Pharmacology
出版年:2017
2.
M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for
NSCLC
作者:
T. Chu
;
L. Jiang
;
W. Ying
;
B. Han
关键词:
Non
;
small
;
cell lung cancer (
NSCLC
)
;
Paclitaxel
;
Cytokeratin 18
;
M30
;
M65
;
Chemotherapy
刊名:Clinical and Translational Oncology
出版年:2017
3.
[18F]FDG PET/CT-based response assessment of
stage
IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches
作者:
Evelyn E. C. de Jong
;
Wouter van Elmpt…
关键词:
[18F]FDG PET/CT
;
Response assessment
;
Nitroglycerin
;
Bevacizumab
;
Stage
IV
NSCLC
刊名:European Journal of Nuclear Medicine and Molecular Imaging
出版年:2017
4.
Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (
NSCLC
): a mutual association with airway disease
作者:
Malik Quasir Mahmood
;
Chris Ward
;
Hans Konrad Muller…
关键词:
EMT
;
S100A4
;
Vimentin
N ;
cadherin
;
Adenocarcinoma
;
Squamous cell carcinoma
;
TNM
刊名:Medical Oncology
出版年:2017
5.
Metabolic tumor volume predicts overall survival and local control in patients with
stage
III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235
作者:
Jose G. Bazan
;
Fenghai Duan…
关键词:
Metabolic tumor volume
;
FDG
;
PET
;
NSCLC
;
SUV
刊名:European Journal of Nuclear Medicine and Molecular Imaging
出版年:2017
6.
The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer
作者:
Hongjing Zang
;
Weiyuan Wang
;
Songqing Fan
关键词:
MicroRNAs
;
Targeted treatment
;
Drug resistance
;
NSCLC
;
EGFR
刊名:Cancer Chemotherapy and Pharmacology
出版年:2017
7.
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in
stage
s IB–IIIA resectable
NSCLC
作者:
John P. Crandall
;
Abdel K. Tahari
;
Rosalyn A. Juergens
;
Julie R. Brahmer…
关键词:
FDG PET/CT
;
FLT PET/CT
;
Non
;
small cell lung cancer
;
Early treatment response monitoring
刊名:EJNMMI Research
出版年:2017
8.
Clinical outcomes of
stage
I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
作者:
Norio Katoh
;
Itaru Soda
;
Hiroyasu Tamamura
;
Shotaro Takahashi…
关键词:
Stereotactic body radiotherapy
;
Non
;
small cell lung cancer
;
Real
;
time tumor
;
tracking radiotherapy
;
Gated radiotherapy
;
Image
;
guided radiotherapy
刊名:Radiation Oncology
出版年:2017
9.
Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early
stage
non-small cell lung cancer (MISSILE-
NSCLC
)
作者:
David A. Palma
;
Timothy K. Nguyen
;
Keith Kwan
;
Stewart Gaede…
关键词:
Non
;
small cell
;
Lung cancer
;
Stereotactic ablative radiotherapy
;
Stereotactic body radiotherapy
;
Surgery
刊名:Radiation Oncology
出版年:2017
10.
Addition of Surgery After Radiation Significantly Improves Survival in
Stage
IIIB Non-small Cell Lung Cancer: A Population-Based Analysis
作者:
Alex Herskovic
;
Bhargava Chitti
;
Paul Christos…
刊名:World Journal of Surgery
出版年:2017
1
2
3
4
5
6
7
8
9
按检索点细分(1065)
题名(35)
关键词(26)
文摘(995)
按出版年细分(1065)
2017年(14)
2016年(50)
2015年(143)
2014年(171)
2013年(132)
2012年(116)
2011年(62)
2010年(57)
2009年(39)
2008年(40)
2007年(41)
2006年(49)
2005年(33)
2004年(18)
2003年(22)
2002年(14)
2001年(21)
2000年(10)
2000年及以前(33)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.